Yang Xiang to Ovarian Neoplasms
This is a "connection" page, showing publications Yang Xiang has written about Ovarian Neoplasms.
Connection Strength
3.267
-
Du M, Peng P, Cao D, Cheng N, Yao L, Sun Y, Li J, Zhang H, Lou G, Tang J, Wang D, Wang Y, Zhang G, Xiang Y. Patient-reported outcomes after long-term period of niraparib maintenance in platinum-sensitive recurrent ovarian cancer: a prospective, multicenter cohort study. J Ovarian Res. 2026 Jan 26; 19(1).
Score: 0.846
-
Zhang Y, Guan Y, Xiao X, Xu S, Zhu S, Cao D, Yu M, Peng P, Wang J, Wang Y, Yin R, Guo J, Gao W, Li P, Bai J, Gong Y, Xia X, Yi X, Yang L, Xiang Y. Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer. BMC Cancer. 2024 Dec 22; 24(1):1565.
Score: 0.784
-
Zhu S, Zhang C, Cao D, Bai J, Yu S, Chen J, Wang J, Ren T, Yang J, Yu M, Xiao X, Gong Y, Guan Y, Li P, Yue Y, Yin R, Wang Y, An R, Lou G, Yuan J, Zhang G, Xia X, Yang L, Xiang Y. Genomic and TCR profiling data reveal the distinct molecular traits in epithelial ovarian cancer histotypes. Oncogene. 2022 05; 41(22):3093-3103.
Score: 0.652
-
Wang D, Jia C, Cheng H, Cao D, Shen K, Yang J, Xiang Y. Analysis of Outcomes and Prognostic Factors after Fertility-Sparing Surgery in Patients with Early Stage Juvenile Granulosa Cell Tumor of the Ovary: Experience from a Tertiary Center. J Pediatr Adolesc Gynecol. 2022 Aug; 35(4):486-491.
Score: 0.635
-
Gui T, Cao D, Yang J, Wei Z, Xie J, Wang W, Xiang Y, Peng P. Early prediction and risk stratification of ovarian cancer based on clinical data using machine learning approaches. J Gynecol Oncol. 2025 07; 36(4):e53.
Score: 0.196
-
Zheng H, Gao Y, Guo H, Li L, Li Q, Cui H, Lin A, Sun L, Hu Y, Kang S, Duan W, Pan L, Wang S, Yang Y, Li Y, Kong W, Xiang Y, Tian X, Ling B, Ha C, Bai W. Real-world Experience of Olaparib Treatment in Patients with Ovarian Cancer: A Chinese Multicenter Study. Mol Cancer Ther. 2021 09; 20(9):1735-1742.
Score: 0.154